Neurological disorders have become the leading cause of disability worldwide, according to a new editorial in The Lancet. The shift carries profound consequences for patients, caregivers, and health-care systems strained by rising caseloads.
As global populations age, the burden of these conditions is expected to increase substantially. The editorial notes that early diagnosis and management remain significant challenges across many health-care settings.
Yet neurology has undergone a dramatic transformation over the past two decades. Advances in genetics, molecular imaging, and biomarkers are moving the field from syndromic classifications to biologically defined disease categories. This change is reshaping how conditions like Alzheimer's and Parkinson's are understood and managed.
Immunotherapies and gene-based approaches are now beginning to modify the natural course of diseases once considered untreatable. These emerging treatments offer new hope but also raise questions about access, cost, and long-term efficacy.
The editorial calls for sustained investment in research and health-care infrastructure to meet the growing challenge. Without such efforts, the gap between scientific progress and patient care may widen further.